BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 15, 2003
View Archived Issues
New therapeutic target for type 2 diabetes: beta-cell apoptosis
Read More
Spotlight on PPAR agonists in development for diabetes mellitus
Read More
Spotlight on contraceptive research
Read More
New beta3-adrenoceptor agonists for urinary incontinence and other uses
Read More
Potassium channel-modulating series described by 4SC researchers
Read More
Selective progesterone receptor modulators prepared and tested at Schering AG
Read More
Wyeth presents new estrogenic agents with potential in menopause, endometriosis, etc.
Read More
Medinox patent covers novel NSAID prodrugs with improved safety profile
Read More
Bayer presents new p38 kinase inhibitors for COPD therapy
Read More
Seroquel approved in Europe for bipolar mania
Read More
Oral dosing of AVI-4557 tested in phase I study
Read More
Betaseron prefilled diluent syringe receives FDA approval
Read More
IPM grant to advance cyanovirin-N development
Read More
Bristol-Myers Squibb and Corgentech to jointly develop E2F decoy
Read More
Independent data support use of M6G for postoperative pain
Read More
Dual-acting anthrax vaccine designed by Boston-based team
Read More
ChemoCentryx awarded grant to develop chemokine-based immunomodulators
Read More
Wyeth advances NSP-989 into phase II
Read More
New data supports Cialis for ED
Read More
Metabolic licenses analgesic compound discovered at university
Read More
Preliminary observations from European trials of Hynic-Annexin V product
Read More
PEG-Intron Redipen approved by FDA
Read More
VaxGen enters license agreement with USAMRIID for vaccine technology
Read More
Selective erbB2 kinase inhibitor CP-654577 inhibits growth of human breast cancer
Read More
Flatfish-derived antimicrobial peptide discovered using genomic approach
Read More